Cogent Biosciences, Inc.
COGT
$37.93
$0.621.66%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.55% | -3.82% | 130.44% | 64.34% | -3.18% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.58% | 19.13% | 50.93% | -11.26% | -0.87% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -8.31% | -3.58% | 129.17% | 62.14% | -3.11% |
|
|
|||||
| Total Current Assets | -8.31% | -3.58% | 129.17% | 62.14% | -3.11% |
| Net Property, Plant & Equipment | 19.80% | -2.92% | -1.38% | -4.34% | -4.24% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -0.04% | -36.62% | -22.95% | -0.78% | 0.00% |
| Total Assets | -7.58% | -3.69% | 120.13% | 54.99% | -3.16% |
|
|
|||||
| Total Accounts Payable | -45.52% | 44.61% | -40.71% | -3.58% | 17.46% |
| Total Accrued Expenses | 19.49% | -11.16% | 6.78% | 11.22% | 17.53% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.66% | -10.60% | -9.32% | 2.90% | 2.92% |
| Total Finance Division Other Current Liabilities | -28.60% | -72.63% | 424.90% | 0.94% | 163.02% |
| Total Other Current Liabilities | -28.60% | -72.63% | 424.90% | 0.94% | 163.02% |
| Total Current Liabilities | 2.27% | -9.34% | 2.74% | 6.55% | 18.46% |
|
|
|||||
| Total Current Liabilities | 2.27% | -9.34% | 2.74% | 6.55% | 18.46% |
| Long-Term Debt | 0.13% | 0.12% | 403.72% | 0.68% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 37.01% | -1.80% | -1.70% | -2.98% | -2.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 45.16% | 87.88% | -98.61% | 0.47% | 47,080.00% |
| Total Liabilities | 2.32% | -1.97% | 143.98% | 3.08% | 84.84% |
|
|
|||||
| Common Stock & APIC | 1.17% | 5.42% | 35.52% | 21.69% | 0.96% |
| Retained Earnings | -7.50% | -8.19% | -9.44% | -8.05% | -7.89% |
| Treasury Stock & Other | -85.54% | -216.90% | 70.67% | 1,500.00% | -92.07% |
| Total Common Equity | -13.87% | -0.74% | 181.15% | 312.87% | -57.48% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | -27.56% | -17.16% | 0.00% | -0.23% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | -27.56% | -17.16% | 0.00% | -0.23% |
|
|
|||||
| Total Common Equity | -13.87% | -0.74% | 181.15% | 312.87% | -57.48% |
| Total Preferred Equity | 0.00% | -27.56% | -17.16% | 0.00% | -0.23% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.39% | -4.51% | 110.40% | 95.09% | -29.21% |
|
|
|||||